✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Norris Medicines Ltd.

NORRIS

Market Cap
₹17 Cr.
P/E
0.00

Norris Medicines Ltd.

  • Norris Medicines
  • Parmax Pharma
  • Colinz Laboratories
FAQs on Norris Medicines Ltd. Shareprice

Norris Medicines has given better returns compared to its competitors.
Norris Medicines has grown at ~40.92% over the last 1yrs while peers have grown at a median rate of -9.0%

Yes, Norris Medicines is expensive.
Latest PE of Norris Medicines is 0.0, while 3 year average PE is -0.05.
Also latest EV/EBITDA of Norris Medicines is 234 while 3yr average is 95.37.

View FAQ's On Business
Growth Table
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Balance Sheet
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Cash Flow
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Quarterly Results
  • Norris Medicines Ltd.
  • Parmax Pharma
  • Colinz Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Norris Medicines Ltd. Financials

Norris Medicines balance sheet is weak and might have solvency issues

Yes, The debt of Norris Medicines is increasing.
Latest debt of Norris Medicines is ₹21.46 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹21.38 Crs.

Yes, profit is increasing.
The profit of Norris Medicines is -₹0.84 Crs for TTM, -₹1.19 Crs for Mar 2024 and -₹1.75 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Norris Medicines latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech